CompoAtlas

BCAAs Plus Arginine with Pterostilbene

Natural health product licensed in Canada

Licence holder
LeralabInc
NPN or DIN-HM
80133765
Status
Active licence
Licence date
23 August 2024
Revision date
Not provided
Form
Liquide oral, poudre
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
L-Leucine

Source : L-Leucine

1,200 mgNot calculated
Acide (S)-2-amino-5-[(aminoiminométhyl)amino]pentanoïque

Source : L-arginine

420 mgNot calculated
L-Isoleucine

Source : L-isoleucine

600 mgNot calculated
L-Valine

Source : L-valine

600 mgNot calculated
4-[(3,5-diméthoxyphényl)éthényl]phénol

Source : Pterocarpus marsupium - duramen (tige)

100 mgNot calculated

Non-medicinal ingredients

Trehalose, Hydroxypropyle Cyclodextrine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years2 Cuillère à café1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

L-Arginine is (a non-essential amino acid) involved in protein synthesis. Source of (an) essential amino acid(s) for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80133765

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line